Skip to main content
. Author manuscript; available in PMC: 2014 Jul 14.
Published in final edited form as: Cell Signal. 2011 Jul 20;23(12):1972–1977. doi: 10.1016/j.cellsig.2011.07.007

Figure 6.

Figure 6

Knockdown of EGFR by siRNA reduces SLO inhibition of human breast cancer MDA-MB-231 cell invasion. A. Immunoblotting of EGFR (upper panel) and actin (lower panel) as a loading control in extracts of cells transfected with a non-targeted (NT) siRNA or with pooled siRNA targeted to EGFR, as described in Materials and Methods. B. The net decrease (control – SLO treated) in number of cells invading through Matrigel in cells transfected with control vs. EGFR targeted siRNA.